Ramkrishna Forgings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 8, 2025, 7:23 pm

Competitors of Ramkrishna Forgings Ltd

All Competitor Stocks of Ramkrishna Forgings Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:45 am

Below is a detailed analysis of the quarterly data for Ramkrishna Forgings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 947.00 Cr. (Mar 2025) to 1,015.00 Cr., marking an increase of 68.00 Cr..
• For Expenses, as of Jun 2025, the value is 873.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 849.00 Cr. (Mar 2025) to 873.00 Cr., marking an increase of 24.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 142.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2025) to 142.00 Cr., marking an increase of 44.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 14.00%, marking an increase of 4.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 7.00 Cr..
• For Interest, as of Jun 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
• For Depreciation, as of Jun 2025, the value is 80.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 85.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from -24.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 41.00 Cr..
• For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from -945.00% (Mar 2025) to 32.00%, marking an increase of 977.00%.
• For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 200.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 188.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.65. The value appears to be declining and may need further review. It has decreased from 11.03 (Mar 2025) to 0.65, marking a decrease of 10.38.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:34 am

Growth

Last Updated: September 5, 2025, 12:55 pm

Balance Sheet

Last Updated: December 4, 2025, 1:52 am

Below is a detailed analysis of the balance sheet data for Ramkrishna Forgings Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 36.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 36.00 Cr..
• For Reserves, as of Sep 2025, the value is 3,031.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,001.00 Cr. (Mar 2025) to 3,031.00 Cr., marking an increase of 30.00 Cr..
• For Borrowings, as of Sep 2025, the value is 2,722.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,126.00 Cr. (Mar 2025) to 2,722.00 Cr., marking an increase of 596.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,098.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,364.00 Cr. (Mar 2025) to 1,098.00 Cr., marking a decrease of 266.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 6,887.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,528.00 Cr. (Mar 2025) to 6,887.00 Cr., marking an increase of 359.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 2,993.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,992.00 Cr. (Mar 2025) to 2,993.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 815.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Mar 2025) to 815.00 Cr., marking an increase of 317.00 Cr..
• For Investments, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 190.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 20.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,869.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,848.00 Cr. (Mar 2025) to 2,869.00 Cr., marking an increase of 21.00 Cr..
• For Total Assets, as of Sep 2025, the value is 6,887.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,528.00 Cr. (Mar 2025) to 6,887.00 Cr., marking an increase of 359.00 Cr..

Notably, the Reserves (3,031.00 Cr.) exceed the Borrowings (2,722.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Ramkrishna Forgings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 22.95. This value is within the healthy range. It has increased from 20.27 (Mar 24) to 22.95, marking an increase of 2.68.
• For Diluted EPS (Rs.), as of Mar 25, the value is 22.95. This value is within the healthy range. It has increased from 20.09 (Mar 24) to 22.95, marking an increase of 2.86.
• For Cash EPS (Rs.), as of Mar 25, the value is 37.97. This value is within the healthy range. It has increased from 33.17 (Mar 24) to 37.97, marking an increase of 4.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 167.78. It has increased from 148.48 (Mar 24) to 167.78, marking an increase of 19.30.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 167.78. It has increased from 148.48 (Mar 24) to 167.78, marking an increase of 19.30.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 222.84. It has increased from 218.77 (Mar 24) to 222.84, marking an increase of 4.07.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 32.37. This value is within the healthy range. It has decreased from 48.07 (Mar 24) to 32.37, marking a decrease of 15.70.
• For PBIT / Share (Rs.), as of Mar 25, the value is 17.38. This value is within the healthy range. It has decreased from 33.82 (Mar 24) to 17.38, marking a decrease of 16.44.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.22. This value is within the healthy range. It has decreased from 25.43 (Mar 24) to 8.22, marking a decrease of 17.21.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 22.99. This value is within the healthy range. It has increased from 18.93 (Mar 24) to 22.99, marking an increase of 4.06.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.93. This value is within the healthy range. It has increased from 18.89 (Mar 24) to 22.93, marking an increase of 4.04.
• For PBDIT Margin (%), as of Mar 25, the value is 14.52. This value is within the healthy range. It has decreased from 21.97 (Mar 24) to 14.52, marking a decrease of 7.45.
• For PBIT Margin (%), as of Mar 25, the value is 7.79. This value is below the healthy minimum of 10. It has decreased from 15.45 (Mar 24) to 7.79, marking a decrease of 7.66.
• For PBT Margin (%), as of Mar 25, the value is 3.68. This value is below the healthy minimum of 10. It has decreased from 11.62 (Mar 24) to 3.68, marking a decrease of 7.94.
• For Net Profit Margin (%), as of Mar 25, the value is 10.31. This value exceeds the healthy maximum of 10. It has increased from 8.65 (Mar 24) to 10.31, marking an increase of 1.66.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.28. This value is within the healthy range. It has increased from 8.63 (Mar 24) to 10.28, marking an increase of 1.65.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.66. This value is below the healthy minimum of 15. It has increased from 12.72 (Mar 24) to 13.66, marking an increase of 0.94.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.34. This value is below the healthy minimum of 10. It has decreased from 16.28 (Mar 24) to 7.34, marking a decrease of 8.94.
• For Return On Assets (%), as of Mar 25, the value is 6.32. This value is within the healthy range. It has decreased from 6.43 (Mar 24) to 6.32, marking a decrease of 0.11.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 0.35, marking an increase of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.66. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 0.66, marking an increase of 0.25.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.67. It has decreased from 0.87 (Mar 24) to 0.67, marking a decrease of 0.20.
• For Current Ratio (X), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 1.5. It has decreased from 1.53 (Mar 24) to 1.10, marking a decrease of 0.43.
• For Quick Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.81 (Mar 24) to 0.55, marking a decrease of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 4. It has increased from 1.87 (Mar 24) to 3.43, marking an increase of 1.56.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.71. This value is below the healthy minimum of 20. It has increased from 7.15 (Mar 24) to 8.71, marking an increase of 1.56.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.26. This value is below the healthy minimum of 20. It has increased from 4.08 (Mar 24) to 5.26, marking an increase of 1.18.
• For Earning Retention Ratio (%), as of Mar 25, the value is 91.29. This value exceeds the healthy maximum of 70. It has decreased from 92.85 (Mar 24) to 91.29, marking a decrease of 1.56.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.74. This value exceeds the healthy maximum of 70. It has decreased from 95.92 (Mar 24) to 94.74, marking a decrease of 1.18.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.53. This value is within the healthy range. It has decreased from 5.73 (Mar 24) to 3.53, marking a decrease of 2.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.01. This value is within the healthy range. It has decreased from 3.26 (Mar 24) to 3.01, marking a decrease of 0.25.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15,976.29. It has increased from 13,433.86 (Mar 24) to 15,976.29, marking an increase of 2,542.43.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.96. This value exceeds the healthy maximum of 3. It has increased from 3.40 (Mar 24) to 3.96, marking an increase of 0.56.
• For EV / EBITDA (X), as of Mar 25, the value is 27.27. This value exceeds the healthy maximum of 15. It has increased from 15.46 (Mar 24) to 27.27, marking an increase of 11.81.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 3. It has increased from 3.16 (Mar 24) to 3.47, marking an increase of 0.31.
• For Retention Ratios (%), as of Mar 25, the value is 91.28. This value exceeds the healthy maximum of 70. It has decreased from 92.84 (Mar 24) to 91.28, marking a decrease of 1.56.
• For Price / BV (X), as of Mar 25, the value is 4.60. This value exceeds the healthy maximum of 3. It has decreased from 4.65 (Mar 24) to 4.60, marking a decrease of 0.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 3. It has increased from 3.16 (Mar 24) to 3.47, marking an increase of 0.31.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness